Abstract:The pacemaker of the 1980s is designed to maintain atrioventricular synchrony through dual-chamber pacing. This pacemaker is multiprogrammable and capable of telemetric transmission of biologic, electronic and electrophysiologic data. Several developments have made this therapeutic modality possible: 1) the cumulative survival rate of many lithium-battery pacemakers exceeds 95% at 5 years; 2) lead and connector problems are rare; 3) atrial and ventricular electrode malfunctions occur in less than 2% of implants; and 4) new introducer techniques have simplified implantation (mortality and major morbidity rates are 0.5 and 0.4%, respectively). With multiprogrammability, pacemaker function can be optimized for the patient's needs, and about 20% of reoperations can be avoided. Ninety-six dual-chamber (DDD) pacemakers, 55 of which have been followed up for more than 3 months, have provided trouble-free performance and have yielded salutary clinical results, particularly when implanted to replace previous ventricular inhibited units. Problems with these pacemakers have included unusual pacing electrocardiograms, pacemaker eccentricities, programmer maintenance, pacing and follow-up complexities and costs. In the 1980s, effort will be required to find a balance between rapidly evolving technology and the clinical need for complex pacing systems. From 1978 to 1981, the rate of pacemaker implantation grew from 309 to 513 implants per million population per year, and there are now approximately 500,000 patients with implanted pacemakers living in the United States. Indications for pacing are ill-defined, because in many cases the assessment of clinical response to pacing is largely subjective, lacking satisfactory quantitative indexes. This decade will be a time of reappraisal of the extent of clinical applicability of new techniques, particularly the multiprogrammable dual-chamber system which, after 3 years of clinical trial, shows promise of being the predominant pacemaker of the immediate future.

Future of Bradyarrhythmia Therapy Systems: Automaticity

Effect of Atrial Pacing Therapy with Selective Pacing Algorithms on Paroxysmal Atrial Fibrillation.

Clinical evaluation of pacemaker automatic capture management and atrioventricular interval extension algorithm.

Electrical Synchrony Optimization for Left Bundle Branch Area Pacing in Patients with Bradycardia and Heart Failure.

Current developments in cardiac rhythm management devices

A preview of implantable cardioverter defibrillator systems in the next millennium: an integrative cardiac rhythm management approach

Pacing devices to treat bradycardia: current status and future perspectives

Induced Pluripotent Stem Cell-Based Treatment Of Acquired Heart Block: The Battle For Tomorrow Has Begun!

Cardiac pacing in the 1980s: treatment and techniques in transition

Implantable Cardiac Devices in Patients with Brady- and Tachy-Arrhythmias: An Update of the Literature

The Clinical Analysis of the Treatment with DDD Pacing in Patients with Bradyarrhythmia

Physiological pacing: just a lot of buzz or the next paradigm shift in bradycardia pacing?

Recent Progression in the clinical application of Permanent cardiac pacemakers

Genetic engineering and cell engineering for repair of damaged atrioventricular conduction or construction of artificial atrioventricular bypass

Is conduction system pacing a panacea for pacemaker therapy?

[Device therapy of chronic heart failure: Update 2015]

Left Bundle Branch Area Pacing Leading the Way: Emerging Trends in Cardiac Pacing

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions

Biological Approaches to Generating Cardiac Biopacemaker for Bradycardia.

Physiology of biventricular pacing

Symptomatic bradyarrhythmias in the athlete - underlying mechanisms and treatments